Valuation: Olympus Corporation

Market Cap 1,805B 11.42B 10.18B 9.42B 8.53B 16.06B 1,078B 16.26B 113B 44.33B 567B 42.84B 41.95B P/E 2027 *
17.3x
P/E 2028 * 14.9x
Enterprise Value 1,889B 11.95B 10.65B 9.86B 8.92B 16.81B 1,128B 17.01B 118B 46.39B 593B 44.84B 43.9B EV / Sales 2027 *
1.75x
EV / Sales 2028 * 1.67x
Free-Float
94.58%
Yield 2027 *
1.8%
Yield 2028 * 1.88%
1 day-2.29%
1 week-14.53%
Current month-15.94%
1 month-16.67%
3 months-2.74%
6 months+7.14%
Current year-15.94%
1 week 10.31
Extreme 10.31
11.11
1 month 10.31
Extreme 10.31
13.24
Current year 8.08
Extreme 8.08
13.72
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 64 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Director/Board Member 59 25/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.29%-14.53% - - 11.63B
+0.97%+4.67%+27.61%+49.46% 254B
+4.29%+4.95%+12.22%+13.62% 158B
-2.26%+1.44%-6.62%+60.40% 155B
-2.35%+2.77%-55.72%-11.07% 66.06B
+0.59%+6.27%+12.12%+59.96% 51.6B
+0.65%+4.48%-13.77%-9.33% 51.82B
+0.12%+3.67%+17.41%+27.23% 50.89B
+2.74%+3.58%+24.30%+62.73% 48.78B
+3.31%+6.59%+33.30%+80.36% 43.51B
Average +0.54%+3.37%+5.65%+37.04% 97.69B
Weighted average by Cap. +0.78%+3.20%+8.73%+38.54%

Financials

2027 *2028 *
Net sales 1,082B 6.85B 6.1B 5.65B 5.11B 9.63B 646B 9.75B 67.74B 26.58B 340B 25.69B 25.15B 1,123B 7.1B 6.33B 5.86B 5.3B 9.99B 670B 10.11B 70.27B 27.57B 352B 26.65B 26.09B
Net income 106B 668M 595M 551M 498M 939M 62.99B 950M 6.6B 2.59B 33.11B 2.5B 2.45B 122B 770M 686M 635M 575M 1.08B 72.68B 1.1B 7.62B 2.99B 38.21B 2.89B 2.83B
Net Debt 84.02B 532M 474M 439M 397M 748M 50.16B 757M 5.26B 2.06B 26.37B 1.99B 1.95B 65.49B 414M 369M 342M 309M 583M 39.1B 590M 4.1B 1.61B 20.55B 1.55B 1.52B
Projected Income Statement - Annual - Olympus Corporation
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
21/10/26 $10.65 -2.29% 130,856
20/10/26 $10.90 +3.42% 148,014
19/10/26 $10.54 -0.85% 63,148
16/10/26 $10.63 -2.16% 42,788
15/10/26 $10.87 -1.67% 92,904
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Olympus Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
1,698.50JPY
Average target price
2,084.62JPY
Spread / Average Target
+22.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Olympus Corporation